| |
- B. Nactergal, J.L. Delvaux, J.-M. Geets, W.J.G.M. Kleeven, T. Vanderlinden, R. Vigneron, S. Zaremba
IBA, Louvain-la-Neuve, Belgium
|
|
| |
In October 2013, IBA sold its first Cyclone®70p, ex-tracted 70 MeV proton machine to Zevacor Pharma, Indianapolis, IN, USA. This brand new machine combine the advantages of the design of the Cyclone®30 HC (1,5mA extracted beam) and the Cyclone®70 XP (multi-particle). Moreover, this high energy cyclotron has been optimized for H− ions acceleration, activation reduction and long term beam production. The installation will be used for high power and long term irradiations of rubidium Rb targets to produce stron-tium 82Sr generator applied in the field of cardiac imaging. From cyclotron to beam lines and up to the target sta-tion, all subsystems have been reviewed to reach highest level of quality, reduce the activation (by the use of low activation material and reduction of beam losses) and finally optimized the maintenance. For that delivery, the machine will be equipped with 6 beam transport lines and 2 solid target station units. In June 2015, about 21 months after contract signature, the IBA Factory Acceptance Tests have been successfully performed in Belgium and the machine was shipped to Indianapolis, IN, USA to be installed in Customer factory cyclotron vault.
|
|